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Abstract: Nucleotide-binding and oligomeriza-
tion domain-like receptors (NLRs) constitute a
family of germline-encoded pattern-recognition re-
ceptors, which allow the host to respond rapidly to
a wide variety of pathogenic microorganisms.
Here, we discuss recent advances in the study of a
subset of NLRs, which control the activation of
caspase-1 through the assembly of large protein
complexes, inflammasomes. The NALP1b inflam-
masome recognizes anthrax lethal toxin, and
flagellin from Salmonella and Legionella induces
assembly of the Ipaf inflammasome. Cryopyrin/
NALP3 mediates caspase-1 activation in response
to a wide variety of bacterial ligands, imidazo-
quinolines, dsRNA, and the endogenous danger sig-
nal uric acid. The importance of these cytosolic
receptors in immune regulation is underscored by
the identification of mutations in cryopyrin/
NALP3, which are genetically linked to human au-
toinflammatory disorders. J. Leukoc. Biol. 82:
220–225; 2007.
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INTRODUCTION
To detect and respond rapidly to diverse groups of microor-
ganisms, the host has evolved a number of germline-encoded
pattern-recognition receptors, which detect conserved micro-
bial and viral components, pathogen-associated molecular pat-
terns (PAMPs) [1]. Bacterial cell wall components such as
peptidoglycan, bacterial flagellin, and nucleic acid structures,
unique to bacteria and viruses, are examples of PAMPs [2].
Members of the TLR family sense the presence of PAMPs
extracellularly and in phagosomes, whereas the cytosolic nu-
cleotide-binding and oligomerization domain (NOD)-like re-
ceptors (NLRs) recognize PAMPs in intracellular compart-
ments. In humans, the latter family is composed of 23 mem-
bers, which share remarkable structural similarity to a subset
of plant disease-resistance genes (R genes) [3]. The amino-
terminal sequence of NLRs generally contains a caspase re-
cruitment domain (CARD), a pyrin domain, baculovirus inhib-
itor repeat (BIR) domains, or a so-called X domain of unknown
function. The central NOD is thought to be involved in self-
oligomerization and activation, and the carboxy-terminal
leucine-rich repeat (LRR) motifs sense specific PAMPs and
autoregulate NLR activity. In this review, we highlight and
discuss recent findings, which contributed significantly to our
understanding of the role of NLR proteins in the activation of
inflammatory caspases.
CASPASES AND THE INFLAMMASOMES
Caspases are cysteinyl aspartate-specific proteases with essen-
tial roles in apoptosis and inflammation [4–6]. They are syn-
thesized as zymogens with a prodomain of variable length,
followed by a large and a small catalytic subunit. In humans,
the caspase family consists of 11 members, which are classified
into three phylogenetic groups, correlating with their function
[7]. The subclass of the inflammatory caspases consists of
caspase-1, -4, and -5 in humans and caspase-1, -11, and -12 in
mice, and caspase-4 and -5 are likely paralogues of murine
caspase-11. As the prototypical member of the inflammatory
caspases, caspase-1 is responsible for the maturation of pro-
IL-1 and pro-IL-18, two related cytokines with critical roles
in inflammation [8, 9]. Indeed, caspase-1-deficient mice have a
defect in the maturation of pro-IL-1 and pro-IL-18 and are
resistant to LPS-induced endotoxic shock [9–11]. Recently,
the IL-1-related cytokine IL-33 was suggested as an additional
caspase-1 substrate [12], although more conclusive evidence
for in vivo caspase-1-mediated processing of this cytokine is
required. A breakthrough in the identification of the mecha-
nisms controlling activation of inflammatory caspases came
from the identification and characterization of the “inflamma-
somes,” large (700 kDa), multiprotein complexes, which re-
cruit inflammatory caspases and trigger their activation [13,
14]. The inflammasomes are often defined by the distinguishing
NLR family member that links recognition of specific patho-
gens to the proximity-induced autoactivation of caspase-1 [4].
Currently, four distinct inflammasomes have been identified:
the NALP1 inflammasome [13, 15], the NALP2 inflammasome
[13, 16], the NALP3 or cryopyrin inflammasome [13, 17–23],
and the IPAF inflammasome [22, 24–26]. The in vitro compo-
sition of the human NALP2 inflammasome has been reported
[13], but a detailed study of the endogenous protein complex
awaits the identification of specific ligands (Fig. 1).
The bipartite adaptor protein ASC has been implicated in
the NALP1-3 and Ipaf inflammasomes [13, 21]. In these com-
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plexes, this 22 kDa adaptor protein bridges the interaction
between NLR proteins and inflammatory caspases through
homotypic interactions with its own amino-terminal pyrin and
carboxy-terminal CARD domains (Fig. 1). As such, ASC plays
a central role in the assembly of the inflammasomes and the
activation of caspase-1 in response to a broad range of PAMPs
and intracellular pathogens [21, 27]. Consistent with this no-
tion, the phenotype of ASC knockout mice mirrors that of
caspase-1-deficient animals, including the marked resistance
to LPS-induced shock [21, 28]. Moreover, the production of the
caspase-1-dependent, proinflammatory cytokines IL-1 and
IL-18 was abolished in ASC-deficient macrophages, which
were infected with intracellular bacteria or stimulated with
bacterial ligands and ATP [21, 27]. In contrast, the secretion of
TNF and IL-6 was not affected, suggesting a specific role for
ASC in caspase-1 activation.
At least in vitro, another adaptor protein containing a CARD
domain, CARDINAL, was shown to interact with caspase-5 and
recruit this inflammatory caspase together with caspase-1 to
the human NALP1 inflammasome [13]. In contrast, an addi-
tional caspase-1 molecule seems to be recruited in the NALP2
and cryopyrin inflammasomes instead of CARDINAL and
caspase-5 [13]. Therefore, the role of CARDINAL and
caspase-5 in the assembly of inflammasome complexes appears
to be more restricted than those of ASC and caspase-1, and
its functional contribution to the human NALP1 inflamma-
some requires further study. Moreover, the gene encoding
CARDINAL does not seem to be present in the mouse genome
(M. Lamkanfi, unpublished results), and there are no reports
currently discussing the roles of the caspase-5 orthologs in
the murine NALP1 inflammasomes. In the following sec-
tions, we will focus on recent findings that revealed how
different pathogens and their ligands activate caspase-1
through the NALP1, Ipaf, and cryopyrin inflammasomes and
discuss the possible existence of additional caspase-1-acti-
vating inflammasomes.
THE NALP1 INFLAMMASOME RESPONDS TO
ANTHRAX LT
LT from Bacillus anthracis is believed to be responsible for
causing death in systemic anthrax infections [29]. This dimeric
toxin consists of the protective antigen subunit, a pore-forming
toxin, which delivers the proteolytic subunit lethal factor into
the cytosol of infected cells [30]. Recent studies revealed that
C57BL/6J macrophages and multiple other inbred mice are
resistant, whereas strains such as 129S1 are highly susceptible
to LT-induced death [31]. Positional cloning studies indicated
that susceptibility maps to mouse chromosome 11 as a single-
dominant locus, designated Ltxs1 [32]. More recently, Boyden
and Dietrich [15] identified the presence of a functional Nalp1b
allele as the key determinant of LT susceptibility in mice.
Indeed, macrophages derived from transgenic mice, which
Fig. 1. Ligands and composition of the
caspase-1 inflammasomes. The NLR pro-
teins NALP1b, NALP2, cryopyrin, and Ipaf
assemble a caspase-1-activating inflamma-
some complex in response to specific mi-
crobial or bacterial factors. The murine
NALP1b inflammasome recognizes the cy-
tosolic presence of anthrax lethal toxin (LT),
whereas the stimulus that triggers the
NALP2 inflammasome remains to be iden-
tified. The cryopyrin inflammasome recog-
nizes multiple PAMPs in combination with
ATP or nigericin, as well as endogenous
danger signals such as uric acid crystals,
which may be released by dying cells. Fi-
nally, the Ipaf inflammasome senses the
cytosolic presence of Salmonella and Legio-
nella flagellin. The CARD/pyrin-containing
inflammasome adaptor apoptosis-associated
speck-like protein (ASC) is essential for all
inflammasome complexes, although its role
in the Nalp1b inflammasome remains to be
formally established.
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express the susceptible Nalp1b allele from 129 S1 mice in a
LT-resistant background, became sensitive to LT-induced tox-
icity [15]. Conversely, inhibition of NALP1b expression using
antisense morpholinos rendered LT-sensitive macrophages re-
sistant. These studies suggest that a functional Nalp1b allele is
required for LT-induced toxicity in mouse macrophages (Fig.
1). In this respect, the Nalp1b gene was found to be extremely
polymorphic, and at least five distinct Nalp1b alleles were
identified in the 18 strains analyzed so far [15]. Two alleles
were found in susceptible strains, whereas the three remaining
alleles correlated with LT-resistant mice. In human macro-
phages, NALP1 interacts with ASC and the adaptor protein
CARDINAL to recruit and activate the inflammatory caspase-1
and -5 [14]. Therefore, the identification of Nalp1b as the gene
conferring LT sensitivity to mouse macrophages suggested a
role for inflammatory caspases in LT-mediated killing of mac-
rophages. Indeed, caspase-1 activation is only detected in
LT-sensitive macrophages, and caspase-1-deficient macro-
phages are resistant to LT-induced death, even in the presence
of a sensitive Nalp1b allele [15]. However, it is unknown
currently whether the mouse orthologs of the remaining com-
ponents of the human NALP1 inflammasome, i.e., ASC and
caspase-11, are also involved in LT-mediated toxicity in mice.
In addition, CARDINAL is not encoded by the murine genome.
It is noteworthy that in this respect, human NALP1 contains a
CARD and pyrin motif to recruit additional inflammasome
components, whereas murine NALP1b is devoid of the pyrin
domain. The functional mechanism that confers resistance to
certain Nalp1b alleles and the molecular determinants of the
interaction between LT and NALP1b that lead to macrophage
killing also warrant further research.
THE IPAF INFLAMMASOME SENSES
BACTERIAL FLAGELLIN
The NLR protein Ipaf is critical for sensing and mounting an
immune response to intracellular pathogens such as Salmo-
nella typhimurium and Legionella pneumophila [22, 24–26].
The potent and rapid activation of caspase-1 seen in macro-
phages infected with these intracellular pathogens is largely
abolished in Ipaf-deficient macrophages. Recently, a number
of elegant studies have identified flagellin from S. typhimurium
and L. pneumophila as the bacterial ligand, which is sensed by
Ipaf [24–26]. Flagellin-deficient bacteria were found to be
compromised in their capability to induce caspase-1 activa-
tion. Cytosolic delivery of bacterial flagellin requires a func-
tional bacterial secretion system (Type III for S. typhimurium
and Type IV for L. pneumophila), although the molecular
mechanism of translocation remains obscure. Direct cytosolic
delivery of recombinant purified flagellin in the absence of
infecting bacteria induces Ipaf-dependent caspase-1 activa-
tion, suggesting that no other bacterial functions but cytosolic
delivery of flagellin are required for Ipaf activation [24–26]. It
is interesting that detection of flagellin by Ipaf and subsequent
caspase-1 activation do not require TLR5, which senses extra-
cellular flagellin [24–26]. These results established a central
role for the Ipaf inflammasome in flagellin-induced caspase-1
activation and IL-1 secretion by S. typhimurium and L. pneu-
mophila (Fig. 1). Furthermore, macrophages are equipped with
at least two flagellin receptors (TLR5 and Ipaf), which seem to
operate in distinct pathways (NF-B activation and caspase-1
activation, respectively). In addition to Ipaf, the adaptor pro-
tein ASC was reported to be required for S. typhimurium-
induced caspase-1 activation [21]. It is unclear currently
whether Ipaf and ASC also sense bacterial flagellin from other
pathogens.
Macrophages from most mouse strains restrict replication of
Legionella, whereas macrophages derived from the A/J strain
are susceptible for Legionella growth [33, 34]. Genetic studies
in mice identified NAIP5/Birc1e as the Legionella susceptibil-
ity locus [35, 36], delineating the importance of this NLR
protein in the control of Legionella replication. Whereas Ipaf
contains an N-terminal CARD domain, NAIP5 harbors three
adjacent BIRs at its N terminus, followed by the centrally
located NOD and C-terminal LRRs, which characterize NLR
proteins [3]. It is interesting that the studies discussed above
showed an increased susceptibility of caspase-1 and Ipaf-
deficient macrophages to Legionella intracellular replication as
a result of an impaired fusion of Legionella-containing phago-
somes with lysosomes [24], similar to observations in A/J
macrophages, carrying a mutated Naip5 allele [37]. A model
that links NAIP5 to the caspase-1 pathway has been proposed
[38–40]. In this model, infection with Legionella activates
NAIP5 by delivering flagellin through its Type IV secretion
system, which then induces the assembly of the IPAF inflam-
masome to activate caspase-1 and restrict Legionella growth. If
this model is correct, caspase-1 activation would be predicted
to be abolished in Naip5-deficient macrophages, as occurs in
Ipaf-deficient cells. Alternatively, Naip5 may control an addi-
tional pathway that restricts Legionella growth, independent of
Ipaf and caspase-1. Clearly, further studies that address these
interesting possibilities are in need.
CRYOPYRIN SENSES MULTIPLE PAMPS AND
ENDOGENOUS DANGER SIGNALS
Recent studies revealed an essential role for cryopyrin/NALP3
and the adaptor protein ASC in mediating caspase-1 activation
in response to several bacterial ligands, nucleic acids, and
synthetic antiviral compounds such as imidazoquinolines (Fig.
1). Indeed, LPS, lipid A, lipoteichoic acid, lipoprotein, and
dsRNA were found to induce potent caspase-1 activation
through cryopyrin upon stimulation of macrophages with mil-
limolar concentrations of ATP [19, 22, 23]. Bacterial RNA and
the imidazoquinoline compounds R837 and R848 alone induce
IL-1 secretion [20], but a brief pulse with ATP enhances
caspase-1 activation and IL-1 maturation. ATP functions by
activating the purinergic P2X7 receptor [41]. Stimulation of the
P2X7 receptor with ATP induces a rapid opening of the potas-
sium-selective channel, followed by the gradual opening of a
larger pore [42, 43], which is mediated by the hemichannel
pannexin-1, recruited upon P2X7 receptor activation [44–46].
Pannexin-1 was found to be critical for caspase-1 activation
and IL-1 secretion in LPS-stimulated macrophages pulsed
with ATP [45]. The bacterially derived potassium ionophore
nigericin and the shellfish toxin maitotoxin can substitute for
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ATP to promote caspase-1 activation in a pannexin-1- [44] and
cryopyrin-dependent manner [22]. Recent evidence indicates
that pannexin-1 mediates the delivery of bacterial molecules
into the cytosol, where they are sensed by cryopyrin and
activate caspase-1 independently of TLR signaling [47]. In-
deed, MyD88; TRIF [Toll/IL-1 receptor (IL-1R) translation
initiation region domain-containing adaptor-inducing IFN-];
and TLR4-deficient macrophages show normal activation of
caspase-1 in response to the TLR4 ligand LPS [28, 47]. The
repertoire of cryopyrin ligands was broadened further with the
discovery that monosodium urate (MSU) and calcium pyro-
phosphate dehydrate (CPPD) crystals, the causative agents of,
respectively, gout and pseudogout, induce cryopyrin-depen-
dent caspase-1 activation in the absence of ATP [18]. It would
be interesting to determine at what level the PAMP/ATP and
the MSU/CPPD pathways merge to signal through the cryopyrin
inflammasome. Finally, Dixit and co-workers [22] reported that
cryopyrin is required specifically for the activation of
caspase-1 in response to the Gram-positive bacteria L. mono-
cytogenes and S. aureus.
The importance of cryopyrin in inflammation has become
apparent with the discovery that gain-of-function mutations
within the NOD of cryopyrin are associated with three hered-
itary periodic fever syndromes, which are characterized by
spontaneous attacks of systemic inflammation, skin rashes, and
prolonged episodes of fever in the absence of any apparent
infectious or autoimmune etiology. These disorders are known
as Muckle-Wells syndrome, familial cold autoinflammatory
syndrome, and neonatal-onset multisystem inflammatory dis-
ease and are referred to collectively as cryopyrin-associated
periodic syndromes (CAPS) [48, 49]. Functional studies re-
vealed that the mutated cryopyrin variants exhibit an enhanced
propensity to induce caspase-1 activation and secrete IL-1
[50]. Consistent with these observations, mononuclear cells
from CAPS patients secrete IL-1 and IL-18 spontaneously
[14, 51]. Administration of an IL-1R antagonist has proven to
be an effective treatment for these autoinflammatory syndromes
and supports the central roles of caspase-1 and IL-1 in the
pathogenesis of these diseases [52]. These findings warrant
further study of the mechanisms controlling the activation of
the cryopyrin inflammasome.
MORE INFLAMMASOMES?
The Gram-negative coccobacillus Francisella tularensis, the
causative agent of tularaemia, escapes from the phagosome to
replicate in the cytosol of infected macrophages. Phagosomal
escape is also linked to the induction of caspase-1 activation as
Franciscella mutants, which cannot escape the vacuole, are
incapable of replicating and activating caspase-1 [53]. The in
vivo response to Franciscella requires ASC and caspase-1, as
bacterial burdens and mortality are increased markedly in ASC
and caspase-1-deficient mice [54]. Studies in macrophages
derived from these mice confirmed that Franciscella-induced
caspase-1 activation requires ASC and thus, suggest the in-
volvement of an inflammasome complex. However, cryopyrin
and Ipaf-deficient macrophages have no apparent defect in
Franciscella-induced caspase-1 activation [22, 54]. It remains
to be clarified whether the NALP1, NALP2 inflammasome, or
another yet-unidentified inflammasome senses the cytosolic
presence of Franciscella. Moreover, the ligand that triggers
caspase-1 activation by this intracellular pathogen is currently
obscure, although it is evident that the Franciscella genome
does not encode flagellin paralogues.
CONCLUSIONS AND PERSPECTIVES
It has now become evident that several NLR family members
fulfill important roles in the assembly of inflammasome com-
plexes to induce caspase-1 activation. However, several im-
portant questions remain, including the identity of microbial
ligands for several inflammasomes and the subcellular local-
ization of inflammasome components. In addition, a better
understanding of the mechanisms involved in microbial recog-
nition is required. Indeed, it is unclear currently whether NLR
family members such as Ipaf or cryopyrin serve as direct
receptors of PAMPs, or instead detect post-translational mod-
ifications of host factors induced by the cytosolic activity of
bacterial elicitors. It is notable that microbial recognition by
NLR homologs in plants has been proposed to proceed largely
through an indirect mechanism [55, 56]. Another important
question is how the release of endogenous danger signals such
as MSU crystals induces inflammasome assembly and
caspase-1 activation. Clearly, elucidating the mechanisms in-
volved in microbial recognition through the NLRs will provide
a clearer insight into the sophisticated system governing
caspase-1 activation and secretion of IL-1 and IL-18. An-
swering these questions will likely contribute to our knowledge
about inflammasome activation and might open up new ave-
nues for therapeutic intervention in inflammatory and infec-
tious diseases.
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